H.B. Fuller Q3 profit rises 17.9% to $79.2M on pricing, but free cash flow halves

The current filing reports environmental remediation liabilities of $4,676 as of August 29, 2026, up from $2,818 a year earlier. The baseline also disclosed a specific CERCLA site in Simpsonville, South Carolina with $508 reserved, but that detail is omitted in the current filing. The increase in total liabilities is material, though the company still states no material adverse effect.

The Rouse lawsuit has moved from an unquantified contingency to a proposed settlement with a $34.8 million accrual ($26.3 million after tax). The company now records a probable loss, whereas previously no loss contingency was recorded. This is a material development in litigation exposure.

Asbestos settlement amounts for the nine months ended August 29, 2026 were $963, up from $369 in the prior-year period. The number of lawsuits settled increased from 7 to 9. Insurance recoveries also increased from $252 to $668. The three-year cumulative settlement amount rose from $5,704 to $5,882.

The company shifted from a revenue decline driven by divestitures and volume to revenue growth driven primarily by pricing, with acquisitions contributing only slightly. This reflects a stronger pricing environment and the absence of the prior year's NA Flooring divestiture impact.

Gross margin expansion slowed from 200 basis points to 120 basis points year-over-year, with the current period benefiting from pricing and restructuring rather than the prior year's distribution cost savings and acquisition/divestiture mix.

Net income and diluted EPS both increased significantly in the current quarter, continuing the upward trend from the prior year. The improvement is consistent with higher revenue and gross margin.

The company also added a new restructuring program for global footprint optimization with expected costs of -50 million.

This is a material new cost initiative not present in the baseline.

Other income surged from $5.3 million to $26.4 million, driven by a $19.7 million unrealized gain on a forward exchange contract related to a pending acquisition. This is a significant non-operating item that boosted reported earnings.

Interest expense increased 21.7% year-over-year, driven by higher debt levels and debt extinguishment costs, reversing the prior year's decline. This reflects increased borrowing and refinancing activity.

The effective tax rate excluding discrete items increased from 24.4% to 26.4%, indicating a higher underlying tax burden in the current period.

Income from the Sekisui-Fuller joint venture increased significantly, from $0.8 million to $2.6 million in the quarter and from $2.7 million to $4.8 million year-to-date, driven by higher joint venture net income.

The company changed its segment performance metric from operating income to Adjusted EBITDA and Adjusted EBITDA margin. This aligns with management's stated use of Adjusted EBITDA for resource allocation and performance assessment.

Cash declined from $122.5 million to $97.2 million year-over-year, while total debt decreased slightly from $2,080.5 million to $2,054.5 million. The debt-to-capital ratio improved from 51.5% to 48.7%.

Free cash flow declined from $62.2 million to $40.9 million year-over-year, driven by higher capital expenditures ($141.7 million vs $94.6 million) and increased working capital usage, despite higher operating cash flow.

DSO increased from 58 to 63 days, inventory days on hand increased from 78 to 88 days, and DPO increased from 69 to 78 days. The deterioration in receivables and inventory turnover contributed to the higher working capital use of cash.

Capital expenditures increased 50% year-over-year, from $94.6 million to $141.7 million, reflecting timing of capital projects and growth initiatives. This is a key driver of the free cash flow decline.

Share repurchases decreased from $60.7 million to $48.9 million year-over-year, indicating a slower pace of buybacks in the current period.

Acquisition spending dropped dramatically from $162.1 million to $3.8 million, and the prior year's $75.7 million divestiture proceeds from NA Flooring did not recur. The current period reflects a much lower level of M&A activity.

The current filing adds a new disclosure explaining that $300 million of 4.0% notes due February 2027 are classified as long-term debt because the company intends and has the ability to refinance them using its revolving credit facility. This is a new disclosure not present in the prior year's Note 1.

The current filing discloses a new pending acquisition of AMS, a UK-listed medical products company, for approximately 659,000 British pounds. The transaction is expected to close by the end of the calendar year, subject to regulatory approvals. This is a significant new strategic development not present in the baseline.

The current filing discloses a new acquisition of Dongguan Nako, a Chinese automated fastener precoating business. The acquisition is expected to accelerate growth in China and includes goodwill. This is a new transaction not present in the baseline.

The current filing discloses a new acquisition of ND Industries Turkey, a specialty adhesives and fastener locking business. The acquisition is expected to accelerate growth in EIMEA and includes goodwill. This is a new transaction not present in the baseline.

The estimated pre-tax costs for the fiscal 2023 restructuring plans have increased from - -. This indicates higher than initially expected restructuring costs.

The current filing discloses new restructuring actions related to global footprint optimization, with expected pre-tax costs. These actions are expected to be completed during fiscal year 2028. This is a new restructuring program not present in the baseline.

The current filing discloses a new amendment to the credit agreement that refinanced Term Loan A and the Revolver, increasing the Revolver from $700 million to $800 million and extending the maturity date to July 17, 2031. The baseline filing disclosed a different refinancing amendment related to Term Loan B. This is a significant change in debt structure.

The current filing discloses new bridge credit agreements totaling up to $3.0 billion to fund the pending AMS acquisition. The Secured Bridge Credit Agreement was terminated on July 17, 2026, and the Unsecured Bridge Credit Agreement has $917 million of commitments with no amounts drawn as of August 29, 2026. This is a new financing arrangement not present in the baseline.

Inventory balances have increased significantly, with total inventory rising. This reflects higher raw materials and finished goods levels, likely due to acquisitions and business growth.

The current period reports smaller discrete tax benefits ( and ) compared to the prior year's benefit and expense. The effective tax rate excluding discrete items increased from 24.4%/25.2% to 26.4%/26.8%, indicating a higher underlying tax rate.

Gross unrecognized tax benefits decreased and accrued interest decreased. This suggests resolution or release of uncertain tax positions during the year.

A new forward contract was entered into to hedge currency risk on the pending AMS acquisition, with a pretax gain of recognized in the current period.

The Level 3 holdback liability decreased and new liabilities related to Dongguan Nako were added. The rollforward shows a payment and additions.

The environmental remediation liability increased from $2,818 at August 30, 2025 to $4,676 at August 29, 2026, a 66% rise. The prior-year comparison also shifted, with the November 2025 balance of $2,625 now lower than the November 2024 balance of $3,445. The company removed the separate disclosure of the Simpsonville, South Carolina CERCLA site allocation that was present in the baseline.

The Rouse litigation moved from an unestimable contingency with no accrual to a probable loss with a $34.8 million accrual ($26.3 million after tax). The company reached a settlement in principle for up to $75.0 million, with payment obligations limited to valid claims and related costs. Preliminary court approval was granted on June 10, 2026, and the accrual remains on the balance sheet at both August 29, 2026 and November 29, 2025.

The company changed its segment performance measure from operating income to Adjusted EBITDA. The chief operating decision maker is now explicitly identified as the chief executive officer. The segment tables now present Adjusted EBITDA, depreciation and amortization, and capital expenditures instead of operating income, and a reconciliation from net income to Adjusted EBITDA is provided.

Share repurchases under the program declined in the first nine months of fiscal 2025 in the first nine months of fiscal 2026, a 20% decrease. No shares were repurchased in the third quarter of either year. The company removed the prior-year comparison for the third quarter of 2024 and nine months ended August 31, 2024 that was present in the baseline.

Asbestos-related lawsuit settlements increased from 7 to 9 in the nine-month period, with settlement amounts rising from $369 to $963. Insurance payments received or expected increased from $252 to $668. The three-year cumulative figures also shifted, with settlements of $5,882 and insurance payments of $3,547 in the current period compared to $5,704 and $3,418 in the baseline.

The company added a new risk factor describing potential shareholder activism, including an unsolicited proposal from Ancora Holdings Group to acquire the Building Adhesive Solutions segment. The board rejected the proposal as undervaluing the business, but the company notes ongoing threats of a public campaign and potential disruption.